Aceto 'No Longer Requires' CEO Kennally
Executive Summary
Aceto has terminated William Kennally’s tenure as president and CEO of the struggling US firm, following deals struck to divest its Rising Pharmaceuticals generics business and chemicals unit as part of bankruptcy proceedings. Meanwhile, the Nasdaq listing has confirmed that Aceto will be delisted in mid-June.
You may also be interested in...
Rogers Becomes Aceto’s President
Steven Rogers has become president of ailing US firm Aceto, in the wake of William Kennally’s termination as president and CEO. Meanwhile, the firm’s chief financial officer has also stepped down.
Aceto Claims That Aurobindo Caused Its Collapse
Aceto has blamed Aurobindo for its downfall, alleging a series of calculated and deceitful actions that have critically wounded the US group’s pharma business. Aurobindo has strongly denied the charges.
Aceto Claims Aurobindo Caused Its Collapse
Aceto has blamed Aurobindo for its downfall, alleging a series of calculated and deceitful actions that have critically wounded the US group’s pharma business. Aurobindo has strongly denied the charges.